PlainAI AI explained plainly

Google DeepMind / Isomorphic Labs · 2025 · 12 · 01 · Impact · ~2 min read

AI-designed drugs entered human trials

DeepMind's protein-prediction breakthroughs reached real patients. Isomorphic Labs — the DeepMind drug-discovery spinoff — moved its first AI-designed cancer and immunology drugs into human trials. The first time medicines designed by AI showed up in actual clinical studies.

What's actually new

  • From prediction to patient. AlphaFold predicted protein shapes; Isomorphic Labs took those predictions and designed actual drugs. By late 2025-early 2026, those drugs entered Phase 1 trials.
  • AlphaFold 3 (May 2024) + AlphaProteo (2024). Together they let researchers design molecules that bind to specific proteins — the foundational work for modern drug discovery, now done in months instead of years.
  • Pharma is paying real money. Eli Lilly, Novartis, and others have multi-billion-dollar deals with Isomorphic Labs. The industry is using AI in drug design at scale, not just talking about it.

If you want more

Worth knowing~30s
  • Phase 1 is the easy part. Most drugs that enter Phase 1 fail Phase 2 or 3. AI-designed drugs are no exception — the real test is whether they help patients more than chemistry-designed drugs do.
  • 'Designed by AI' has marketing pull the science doesn't fully justify yet. Human chemists still curate, validate, and adjust every candidate before it reaches a patient.
  • The timeline-shrinking claims need years of evidence before they're proven.
Who should care~20s

Anyone in healthcare, pharma, or biotech. Patients with rare diseases waiting for affordable treatments. Investors tracking how AI changes industries beyond software. Anyone curious whether 'AI cures cancer' headlines have any substance.

What to do about it~20s

Watch the Phase 2 trial data over 2026-2027. That's when we'll know whether AI-designed medicines actually work better — or just arrive faster. If you're in pharma, the question isn't 'should we use AI?' anymore but 'how do we structure deals with the tools that work?'

Honest take~45s

AlphaFold's legacy in 2025-2026 became real, not theoretical. The protein-folding problem was solved; what mattered next was whether researchers could turn predictions into medicines. Isomorphic Labs proved the answer is yes — at least far enough to put pills in human bodies. The cancer and immunology candidates may or may not work; the meta-fact that AI-designed drugs reached the clinic at all is the headline. Drug discovery is being rewritten in slow motion, and most people outside the field haven't noticed.

Other recent impact updates

Sources

Last verified · 2026 · 05 · 05 · Found a fact wrong? corrections@aguidetocloud.com